A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit

Drug Resistance

Impact of psychologically tailored hand hygiene interventions on nosocomial infections with multidrug-resistant organisms: results of the cluster-randomized controlled trial PSYGIENE

Antimicrob Resist Infect Control.

von Lengerke T, Ebadi E, Schock B, Krauth C, Lange K, Stahmeyer JT, Chaberny IF

doi: 10.1186/s13756-019-0507-5.

Bacterial InfectionsDrug Resistance

The effects of antibiotic cycling and mixing on antibiotic resistance in intensive care units: a cluster-randomised crossover trial

Lancet Infect Dis.

van Duijn PJ, Verbrugghe W, Jorens PG, Spöhr F, Schedler D, Deja M, Rothbart A, Annane D, Lawrence C, Nguyen Van JC, Misset B, Jereb M, Seme K, Šifrer F, Tomiç V, Estevez F, Carneiro J, Harbarth S, Eijkemans MJC, Bonten M; SATURN consortium

doi: 10.1016/S1473-3099

Drug Resistance

The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017

Antimicrob Resist Infect Control.

Ayobami O, Willrich N, Suwono B, Eckmanns T, Markwart R

doi: 10.1186/s13756-020-00750-5.

Drug Resistance

European intensive care physicians' experience of infections due to antibiotic-resistant bacteria

doi: 10.1186/s13756-019-0662-8.

Bacterial Infections

Management of infected pancreatic necrosis in the intensive care unit: a narrative review

Clin Microbiol Infect.

Wolbrink DRJ, Kolwijck E, Oever JT, Horvath KD, Bouwense SAW, Schouten JA

doi: 10.1016/j.cmi.2019.06.017.

Drug Resistance

Risk perception of the antimicrobial resistance by infection control specialists in Europe: a case-vignette study

Antimicrob Resist Infect Control.

Birgand G, Mutters NT, Ahmad R, Tacconelli E, Lucet JC, Holmes A, Percept-R Study Group.

doi: 10.1186/s13756-020-0695-z.

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

Lancet Infect Dis.

Paul M, Daikos GL, Durante-Mangoni E, Yahav D, Carmeli Y, Benattar YD, Skiada A, Andini R, Eliakim-Raz N, Nutman A, Zusman O, Antoniadou A, Pafundi PC, Adler A, Dickstein Y, Pavleas I, Zampino R, Daitch V, Bitterman R, Zayyad H, Koppel F, Levi I, Babich T, Friberg LE, Mouton JW, Theuretzbacher U, Leibovici L

doi: 10.1016/

Drug Resistance

Using machine learning to optimise antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii

Clin Microbiol Infect.

Smith NM, Lenhard JR, Boissonneault KR, Landersdorfer CB, Bulitta JB, Holden PN, Forrest A, Nation RL, Li J, Tsuji BT

doi: 10.1016/j.cmi.2020.02.004.

Drug Resistance

Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial

Lancet.

Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Heim L, Gombosev A, Avery TR, Haffenreffer K, Shimelman L, Hayden MK, Weinstein RA, Spencer-Smith C, Kaganov RE, Murphy MV, Forehand T, Lankiewicz J, Coady MH, Portillo L, Sarup-Patel J, Jernigan JA, Perlin JB, Platt R; ABATE Infection trial team

doi: 10.1016/S0140-6736(18)32593-5.

Related content

Impact of psychologically tailored hand hygiene interventions on nosocomial infections with multidrug-resistant organisms: results of the cluster-randomized controlled trial PSYGIENE

The effects of antibiotic cycling and mixing on antibiotic resistance in intensive care units: a cluster-randomised crossover trial

The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017

European intensive care physicians' experience of infections due to antibiotic-resistant bacteria

Management of infected pancreatic necrosis in the intensive care unit: a narrative review

Risk perception of the antimicrobial resistance by infection control specialists in Europe: a case-vignette study

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

Using machine learning to optimise antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii

Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial